Patrick C. Roche

19.9k total citations · 5 hit papers
142 papers, 15.1k citations indexed

About

Patrick C. Roche is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Patrick C. Roche has authored 142 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 54 papers in Oncology and 28 papers in Pathology and Forensic Medicine. Recurrent topics in Patrick C. Roche's work include HER2/EGFR in Cancer Research (20 papers), Monoclonal and Polyclonal Antibodies Research (20 papers) and Advanced Biosensing Techniques and Applications (14 papers). Patrick C. Roche is often cited by papers focused on HER2/EGFR in Cancer Research (20 papers), Monoclonal and Polyclonal Antibodies Research (20 papers) and Advanced Biosensing Techniques and Applications (14 papers). Patrick C. Roche collaborates with scholars based in United States, Ireland and Australia. Patrick C. Roche's co-authors include Esteban Celis, Scott E. Strome, Lieping Chen, Haidong Dong, Dallas B. Flies, Hideto Tamura, Gefeng Zhu, Fumiya Hirano, Koji Tamada and Jun Lü and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Patrick C. Roche

141 papers receiving 14.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2002 4.0k citations Patrick C. Roche et al. profile →
Adoptive T cell therapy using antigen-specific CD8⁺T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells

2002 941 citations Patrick C. Roche et al. profile →
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

1998 698 citations Patrick C. Roche et al. profile →
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice

2004 586 citations Rajiv Kumar, Robert B. Jenkins et al. profile →
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

1998 541 citations Patrick C. Roche et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick C. Roche United States	53	7.7k	4.6k	4.2k	2.7k	2.2k	142	15.1k
James D. Griffin United States	95	7.4k 1.0×	12.8k 2.8×	5.3k 1.3×	1.7k 0.6×	1.9k 0.9×	354	29.7k
Giorgio Cattoretti Italy	54	4.2k 0.5×	6.6k 1.4×	4.9k 1.2×	3.6k 1.3×	845 0.4×	183	16.3k
Kohzoh Imai Japan	75	5.4k 0.7×	10.5k 2.3×	2.6k 0.6×	2.1k 0.8×	1.9k 0.9×	434	18.8k
Dontscho Kerjaschki Austria	79	6.7k 0.9×	8.4k 1.8×	3.6k 0.9×	1.5k 0.6×	2.1k 1.0×	225	21.3k
Ahmet Doǧan United States	69	5.8k 0.8×	6.1k 1.3×	2.9k 0.7×	6.5k 2.4×	1.5k 0.7×	382	16.9k
C. Blake Gilks Canada	63	5.0k 0.6×	4.2k 0.9×	1.9k 0.5×	2.3k 0.9×	2.3k 1.1×	179	14.3k
Lalage M. Wakefield United States	64	6.9k 0.9×	13.6k 3.0×	3.3k 0.8×	1.6k 0.6×	2.1k 1.0×	150	23.2k
Allen M. Gown United States	68	6.4k 0.8×	5.0k 1.1×	1.1k 0.3×	2.3k 0.9×	3.8k 1.7×	191	16.1k
C. Blake Gilks Canada	75	4.6k 0.6×	4.6k 1.0×	1.6k 0.4×	2.1k 0.8×	2.5k 1.2×	291	16.7k
Xavier Matías‐Guiu Spain	64	4.2k 0.5×	6.4k 1.4×	1.2k 0.3×	2.4k 0.9×	1.8k 0.8×	435	16.1k

Countries citing papers authored by Patrick C. Roche

Since Specialization

Citations

This map shows the geographic impact of Patrick C. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Roche more than expected).

Fields of papers citing papers by Patrick C. Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Roche. The network helps show where Patrick C. Roche may publish in the future.

Co-authorship network of co-authors of Patrick C. Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick C. Roche. A scholar is included among the top collaborators of Patrick C. Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick C. Roche. Patrick C. Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roche, Patrick C., et al.. (2021). Portable analyser using two-dimensional ion chromatography with ultra-violet light-emitting diode-based absorbance detection for nitrate monitoring within both saline and freshwaters. Journal of Chromatography A. 1652. 462368–462368. 16 indexed citations

Fitzgibbons, Patrick L., Douglas A. Murphy, David M. Dorfman, Patrick C. Roche, & Raymond R. Tubbs. (2006). Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey.. Archives of Pathology & Laboratory Medicine. 130(10). 1440–5. 28 indexed citations

Mariani, Andrea, Thomas J. Sebo, Jerry A. Katzmann, et al.. (2005). Endometrial cancer: can nodal status be predicted with curettage?. Gynecologic Oncology. 96(3). 594–600. 22 indexed citations

Roche, Patrick C., VJ Suman, Robert B. Jenkins, et al.. (2002). Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831. JNCI Journal of the National Cancer Institute. 94(11). 855–857. 313 indexed citations

Tubbs, Raymond, James Pettay, Marek Skacel, et al.. (2002). Gold-Facilitated in Situ Hybridization. American Journal Of Pathology. 160(5). 1589–1595. 39 indexed citations

Nagle, Raymond B., Patrick C. Roche, Eric D. Hsi, et al.. (2002). Clinical laboratory assays for HER-2/neu amplification and overexpression: Quality assurance, standardization, and proficiency testing. Archives of Pathology & Laboratory Medicine. 126(7). 803–808. 65 indexed citations

Perez, Edith A., Patrick C. Roche, Robert B. Jenkins, et al.. (2002). HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization. Mayo Clinic Proceedings. 77(2). 148–154. 157 indexed citations

Roche, Patrick C., et al.. (2001). Utilization of gene expression profiling to identify markers of disease recurrence in node-negative breast cancer. Breast Cancer Research and Treatment. 69(3). 1 indexed citations

Roche, Patrick C., et al.. (2000). Molecular and Cytokinetic Pretreatment Risk Assessment in Endometrial Carcinoma. Gynecologic Oncology. 77(1). 1–7. 24 indexed citations

10.

Dong, X., Ratnam S. Seelan, Kazuhiro Taniguchi, et al.. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000). Data Archiving and Networked Services (DANS). 3 indexed citations

11.

Dockrell, David H., Andrew D. Badley, Jorge Villacian, et al.. (1998). The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.. Journal of Clinical Investigation. 101(11). 2394–2405. 110 indexed citations

12.

Rayson, Daniel, Charles Erlichman, Vera J. Suman, et al.. (1998). Molecular markers in male breast carcinoma. Cancer. 83(9). 1947–1955. 113 indexed citations

13.

Badley, Andrew D., David H. Dockrell, Steve Ziesmer, et al.. (1998). In vivo analysis of Fas/FasL interactions in HIV-infected patients.. Journal of Clinical Investigation. 102(1). 79–87. 137 indexed citations

14.

Rhoton-Vlasak, Alice, Jill M. Wagner, Joanne L. Rutgers, et al.. (1998). Placental site trophoblastic tumor: Human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. Human Pathology. 29(3). 280–288. 19 indexed citations

15.

Cliby, William A., Gary L. Keeney, Vera J. Suman, et al.. (1997). Expression of nm23/Nucleoside Diphosphate Kinase-A Protein in Endometrial Carcinoma. Gynecologic Oncology. 66(2). 238–245. 4 indexed citations

16.

Johnson, Julie A., Joseph P. Grande, Patrick C. Roche, & Rajiv Kumar. (1996). Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochemistry and Cell Biology. 105(1). 7–15. 97 indexed citations

17.

Lacy, Martha Q., Lynn C. Hartmann, Gary L. Keeney, et al.. (1995). c-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer. 75(12). 2891–2896. 28 indexed citations

18.

Limper, Andrew H., et al.. (1994). Immunohistochemical Localization of Transforming Growth Factor-Beta 1 in the Nonnecrotizing Granulomas of Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 149(1). 197–204. 73 indexed citations

19.

Hetzel, David J., Timothy O. Wilson, Gary L. Keeney, et al.. (1992). HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecologic Oncology. 47(2). 179–185. 175 indexed citations

20.

Butterfield, Joseph H., et al.. (1990). Purification of Tryptase From a Human Mast Cell Line. Journal of Leukocyte Biology. 47(5). 409–419. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact